English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community
Press release submission | Apr 26, 2018

CLEVELAND CLINIC: Study says Genetics May Be to Blame for Child’s Picky Eating

Press release submission | Apr 26, 2018

UNIVERSITY OF CALIFORNIA SAN FRANCISCO: Giacomini named 2018 Volwiler Research Award recipient

Press release submission | Apr 26, 2018

AMERICAN CANCER SOCIETY - CINCINNATI: Researchers Report Advances in Lung Cancer Immunotherapy

Press release submission | Apr 26, 2018

UNIVERSITY OF CALIFORNIA SAN FRANCISCO: Gene Mapping Lays Groundwork for Precision Chemotherapy

Press release submission | Apr 26, 2018

AMERICAN CANCER SOCIETY CANCER ACTION NETWORK: CDC Launches New Round of Powerful Tobacco Cessation Ads

Press release submission | Apr 25, 2018

CLEVELAND CLINIC: Children with Autism Less Likely to Get Critical Vaccines

Press release submission | Apr 25, 2018

UNIVERSITY OF CALIFORNIA SAN FRANCISCO: Football Scuffles, Auto Injuries May Raise Risk for Parkinson’s

Press release submission | Apr 25, 2018

ELI LILY AND COMPANY: AAN 2018: Lilly's Galcanezumab Significantly Reduced Monthly Migraine Headache Days in Patients with Migraine Who Previously Failed to Respond to Multiple Preventive Therapies

Trending

+ Pharmaceuticals
Patient Daily | Jun 30, 2025

PhRMA public affairs senior director on 340B program: 'PBMs took $140 billion in rebates and fees, driving up American medicine costs'

+ Pharmaceuticals
Patient Daily | Jun 23, 2025

PhRMA says patients in the U.S. face higher prescription costs due to 340B program

+ Pharmaceuticals
Patient Daily | Jun 25, 2025

Neurosurgeon at the University of California: ‘340B is being exploited for profit, not patient care’

  • « First
  • «
  • …
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • …
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2025 Patient Daily